Krystal Biotech's change in inventory for the quarter that ended in Dec. 2024 was $-6.5 Mil. It means Krystal Biotech's inventory
increased by $6.5 Mil
from Sep. 2024 to Dec. 2024 .
Krystal Biotech's change in inventory for the fiscal year that ended in Dec. 2024 was $-11.9 Mil. It means Krystal Biotech's inventory
increased by $11.9 Mil
from Dec. 2023 to Dec. 2024 .
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Krystal Biotech's Days Inventory for the quarter that ended in Dec. 2024 was 415.68.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Krystal Biotech's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.22.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Krystal Biotech's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.25.
Krystal Biotech Change In Inventory Historical Data
The historical data trend for Krystal Biotech's Change In Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.
Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krystal Biotech (NAS:KRYS) Change In Inventory Explanation
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Krystal Biotech's Days Inventory for the quarter that ended in is calculated as:
3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Krystal Biotech's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krystal Biotech Change In Inventory Related Terms
Thank you for viewing the detailed overview of Krystal Biotech's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KRYS has been successfully added to your 